Reactions included nausea, vomiting, chills, low blood pressure, difficulty breathing , and in some cases, possible bloodstream infection
Q: Is BPC-157 legal and safe to use
If the FDA eventually adds the peptide to the 503A Bulks List, practices considering offering compounded BPC-157 should carefully evaluate: State laws governing prescribing and administration
Patients are encouraged to discuss the risks, benefits, and appropriateness of any medications, including compounded products, with their healthcare provider before use.
Additional Monitoring May Be Considered In: Higher-frequency regenerative research protocols Long-duration experimental protocols Multiple concurrent regenerative or metabolic-support compounds Significant peptide-sensitivity research models Liver-function or copper-metabolism-related investigations due to the inclusion of GHK-Cu Avoid or Carefully Evaluate In Research Models With: Known hypersensitivity to peptide compounds Active severe systemic illness Severe uncontrolled cardiovascular, metabolic, or neurological conditions Active or suspected malignancy-related, tumor-related, or abnormal proliferative conditions Pregnancy or breastfeeding contexts Additional Research Considerations Because Glow Blend contains GHK-Cu, prolonged or higher-frequency research exposure may influence copper and zinc balance in some research settings
.png?sfvrsn=1e7191c0_3)
